Marriott International Inc vs Nuwellis Inc — how do they compare? Marriott International Inc trades at $366.01 (market cap $94.16B), while Nuwellis Inc trades at $0.68 (market cap $2.20M). The key difference: Marriott International Inc is far larger — about 42800× Nuwellis Inc's market cap, and Marriott International Inc pays a 0.81% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Marriott International Inc for 164 Days and Nuwellis Inc for 26 Days on average.
| MAR | NUWE | |
|---|---|---|
Market Cap | $94.16B | $2.20M |
Volume | 996,176 | 121,544 |
Sector | Consumer Cyclical | Health |
52-Week High | $402.54 | $146.65 |
52-Week Low | $259.04 | $0.68 |
Typical Hold Time | 164 Days | 26 Days |
Enterprise Value | $111.47B | -$1.52M |
Dividend Yield | 0.81% | — |
Signals from Pluang's Aura AI — not financial advice
Marriott International (MAR) trades at $363.49, up 1.96% today, showing strong momentum near resistance at $364. The stock maintains a bullish technical outlook with positive moving averages and ADX signals. Fundamentally, revenue grew to $26.19B in 2025 with a 9.62% net margin, though valuation metrics appear elevated with a P/E of 37.38. Recent earnings beat expectations in Q1 and Q2 2026, while analysts maintain a consensus price target of $386.71 with 44% buy ratings.
Outlook remains positive driven by travel demand recovery and strategic partnerships, but risks include rising debt levels (debt-to-asset ratio at 58.83% in 2025) and economic sensitivity. The stock offers moderate upside to analyst targets with institutional confidence, though high valuation requires sustained earnings growth to justify current levels.
NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.
The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Marriott International Inc. of Maryland is a worldwide operator and franchisor of hotels. The Company franchises lodging facilities and vacation timesharing resorts under various brand names. Marriott also provides services to home and condominium owner associations for projects associated with several of its brands.
Read more on MAR →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →